ArticleJPRAS open2026
Postoperative complications of breast risk-reduction surgery in very high risk breast cancer patients: A series of 253 cases.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study assesses surgical practices and complications related to risk-reducing mastectomy in patients at very high risk for breast cancer. Methods: A retrospective study was conducted among women over 18 years of age who had undergone risk-reducing mastectomy from January 2015 to April 2022 at the Toulouse-Oncopole University Cancer Institute. Results: For the 253 patients having undergone risk-reducing mastectomy between 2015 and 2022, mean age was 43 years, with a majority of patients carrying BRCA1 (48.6%) or BRCA2 mutations (38.3%). Three-quarters of patients (67.6%) underwent prosthetic reconstruction, 17% free-flap reconstruction, and 7% latissimus dorsi flap reconstruction. At least one postoperative complication was experienced by 43% of patients, mostly wound healing disorders (34.9%). A complication requiring no further intervention was recorded in 32% of patients. A further 11.1% required reoperation. Implant loss occurred in 3.5% of patients undergoing prosthetic reconstruction. The rate of free flap loss was 5.9%. Discussion and conclusion: The overall complication rate of 43% aligns with findings from other studies on risk-reducing mastectomy, with notable variations between prosthetic and autologous reconstructions. This study highlights the high complication rates associated with risk-reducing mastectomies, especially in patients undergoing free-flap reconstruction. Despite these challenges, the rates of reconstruction failure and severe complications remain relatively low. Understanding patient-specific risk factors and surgical modalities can help in counseling patients and managing their expectations about potential postoperative issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.